FDA approves Dr Reddy’s Vascepa generic
13-08-2020
Fed Circuit affirms generic maker’s win over Eagle
11-05-2020
Igorgolovniov / Shutterstock.com
London-based Hikma Pharmaceuticals has won approval to launch the first generic version of Vascepa (icosapent ethyl), after having key Amarin patents for the heart drug invalidated.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, Hikma, Amarin, Vascepa, Dr Reddy’s, ANDA, generics, Securities Exchange Commission, COVID-19
